EGFR and glioblastoma: Shinojima et al. analyzed the prognostic value of EGFR gene amplification and mutation in 87 patients with newly diagnosed glioblastoma and demonstrated that EGFRvIII expression in the presence of EGFR gene amplification is an independent indicator and is the strongest indicator of a poor survival prognosis [34].